Clinical trials
Non-alcoholic Fatty Liver Disease trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 2 |
| Anton Skaro | 1 |
| LMC Diabetes & Endocrinology Ltd. | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| University of Alberta | 1 |
| University of Calgary | 1 |
| University of Western Ontario, Canada | 1 |
| Valbiotis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 10 |
| Fatty Liver | 3 |
| Insulin Resistance | 3 |
| Metabolic Syndrome | 3 |
| Overweight | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Endotoxemia | 2 |
| Liver Cirrhosis | 2 |
| Obesity | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.